
FONAR Corporation – NASDAQ:FONR
FONAR stock price today
FONAR stock price monthly change
FONAR stock price quarterly change
FONAR stock price yearly change
FONAR key metrics
Market Cap | 95.51M |
Enterprise value | 93.79M |
P/E | 12.98 |
EV/Sales | 0.96 |
EV/EBITDA | 3.95 |
Price/Sales | 1.08 |
Price/Book | 0.70 |
PEG ratio | 0.43 |
EPS | 1.58 |
Revenue | 101.72M |
EBITDA | 23.19M |
Income | 10.62M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 6.83% |
Oper. margin | 18.51% |
Gross margin | 47.44% |
EBIT margin | 18.51% |
EBITDA margin | 22.8% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeFONAR stock price history
FONAR stock forecast
FONAR financial statements
Jun 2022 | 24.81M | 3.65M | 14.72% |
---|---|---|---|
Mar 2023 | 25.42M | 3.86M | 15.18% |
Jun 2023 | 25.77M | 1.23M | 4.8% |
Mar 2024 | 25.71M | 1.87M | 7.28% |
Dec 2022 | 197498000 | 49.42M | 25.03% |
---|---|---|---|
Mar 2023 | 199336000 | 48.71M | 24.44% |
Jun 2023 | 200581887 | 49.75M | 24.81% |
Mar 2024 | 209631000 | 52.60M | 25.09% |
Jun 2022 | 5.18M | -766.32K | -1.70M |
---|---|---|---|
Mar 2023 | 4.28M | -2.20M | -1.94M |
Jun 2023 | 4.31M | -698.12K | -1.98M |
Mar 2024 | 2.86M | -289K | -1.81M |
FONAR alternative data
Aug 2023 | 484 |
---|---|
Sep 2023 | 484 |
Oct 2023 | 484 |
Nov 2023 | 561 |
Dec 2023 | 561 |
Jan 2024 | 561 |
Feb 2024 | 561 |
Mar 2024 | 561 |
Apr 2024 | 561 |
May 2024 | 561 |
Jun 2024 | 561 |
Jul 2024 | 561 |
FONAR other data
Period | Buy | Sel |
---|---|---|
Sep 2022 | 9400 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | BONANNI LUCIANO B officer: Exec VP, COO & PFO | FONAR CORPORATION COMMON STOCK | 3,400 | $14.16 | $48,144 | ||
Purchase | DAMADIAN TIMOTHY RAYMOND director, officer: CEO, Preside.. | FONAR CORPORATION COMMON STOCK | 2,200 | $14.15 | $31,130 | ||
Purchase | BONANNI LUCIANO B officer: Exec VP, COO & PFO | FONAR CORPORATION COMMON STOCK | 1,300 | $13.82 | $17,966 | ||
Purchase | DAMADIAN TIMOTHY RAYMOND director, officer: CEO, Preside.. | FONAR CORPORATION COMMON STOCK | 2,500 | $13.63 | $34,075 | ||
Sale | DAMADIAN RAYMOND V director, 10 perc.. | FONAR CORPORATION COMMON STOCK | 450 | $24.65 | $11,093 | ||
Sale | DAMADIAN RAYMOND V director, 10 perc.. | FONAR CORPORATION COMMON STOCK | 450 | $24.65 | $11,093 | ||
Sale | DAMADIAN RAYMOND V director, 10 perc.. | FONAR CORPORATION COMMON STOCK | 600 | $24.8 | $14,880 | ||
Sale | DAMADIAN RAYMOND V director, 10 perc.. | FONAR CORPORATION COMMON STOCK | 1,800 | $24.6 | $44,280 | ||
Sale | DAMADIAN RAYMOND V director, 10 perc.. | FONAR CORPORATION COMMON STOCK | 633 | $26.58 | $16,825 | ||
Sale | DAMADIAN RAYMOND V director, 10 perc.. | FONAR CORPORATION COMMON STOCK | 607 | $26.46 | $16,061 |
Patent |
---|
Grant Filling date: 30 May 2019 Issue date: 9 Aug 2022 |
Grant Filling date: 1 Aug 2016 Issue date: 3 May 2022 |
Grant Utility: Cervical vertebra angle measurement Filling date: 13 Mar 2014 Issue date: 12 Oct 2021 |
Grant Utility: Method and system for performing upright magnetic resonance imaging of various anatomical and physiological conditions Filling date: 29 Sep 2017 Issue date: 31 Aug 2021 |
Grant Filling date: 18 Mar 2019 Issue date: 4 May 2021 |
Grant Filling date: 9 Jan 2018 Issue date: 1 Dec 2020 |
Grant Filling date: 28 Jul 2016 Issue date: 13 Oct 2020 |
Grant Utility: Magnetic resonance imaging Filling date: 12 Jul 2017 Issue date: 8 Oct 2019 |
Insider | Compensation |
---|---|
Dr. Raymond V. Damadian M.D. (1936) Chairman, Treasurer & Principal Financial Officer | $458,890 |
Mr. Timothy R. Damadian (1964) Pres & Chief Executive Officer | $155,800 |
Mr. Luciano B. Bonanni (1955) Chief Operating Officer & Executive Vice President | $146,040 |
Ms. Claudette J. V. Chan (1938) Sec. & Director | $20,000 |
-
What's the price of FONAR stock today?
One share of FONAR stock can currently be purchased for approximately $15.11.
-
When is FONAR's next earnings date?
Unfortunately, FONAR's (FONR) next earnings date is currently unknown.
-
Does FONAR pay dividends?
No, FONAR does not pay dividends.
-
How much money does FONAR make?
FONAR has a market capitalization of 95.51M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.3% to 102.88M US dollars.
-
What is FONAR's stock symbol?
FONAR Corporation is traded on the NASDAQ under the ticker symbol "FONR".
-
What is FONAR's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of FONAR?
Shares of FONAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are FONAR's key executives?
FONAR's management team includes the following people:
- Dr. Raymond V. Damadian M.D. Chairman, Treasurer & Principal Financial Officer(age: 89, pay: $458,890)
- Mr. Timothy R. Damadian Pres & Chief Executive Officer(age: 61, pay: $155,800)
- Mr. Luciano B. Bonanni Chief Operating Officer & Executive Vice President(age: 70, pay: $146,040)
- Ms. Claudette J. V. Chan Sec. & Director(age: 87, pay: $20,000)
-
How many employees does FONAR have?
As Jul 2024, FONAR employs 561 workers.
-
When FONAR went public?
FONAR Corporation is publicly traded company for more then 43 years since IPO on 29 Oct 1981.
-
What is FONAR's official website?
The official website for FONAR is fonar.com.
-
Where are FONAR's headquarters?
FONAR is headquartered at 110 Marcus Drive, Melville, NY.
-
How can i contact FONAR?
FONAR's mailing address is 110 Marcus Drive, Melville, NY and company can be reached via phone at +63 16942929.
FONAR company profile:

FONAR Corporation
fonar.comNASDAQ
520
Medical - Devices
Healthcare
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Melville, NY 11747
CIK: 0000355019
ISIN: US3444374058
CUSIP: 344437405